Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $8.67 Million - $9.88 Million
-112,203 Reduced 8.52%
1,204,538 $99.9 Million
Q4 2022

Feb 08, 2023

BUY
$62.32 - $89.47 $15.6 Million - $22.4 Million
249,941 Added 23.43%
1,316,741 $113 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $63.5 Million - $72.6 Million
1,066,800 New
1,066,800 $65.8 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $20.1 Million - $22.9 Million
-355,411 Closed
0 $0
Q3 2020

Nov 10, 2020

SELL
$62.1 - $78.08 $33.7 Million - $42.4 Million
-542,431 Reduced 60.41%
355,411 $22.5 Million
Q2 2020

Jul 30, 2020

BUY
$72.34 - $84.0 $540,741 - $627,900
7,475 Added 0.84%
897,842 $69.1 Million
Q1 2020

May 07, 2020

SELL
$62.63 - $80.22 $38.8 Million - $49.6 Million
-618,729 Reduced 41.0%
890,367 $66.6 Million
Q4 2019

Feb 05, 2020

SELL
$61.62 - $67.78 $19.4 Million - $21.4 Million
-315,194 Reduced 17.28%
1,509,096 $98.1 Million
Q3 2019

Nov 06, 2019

SELL
$62.51 - $69.0 $3.11 Million - $3.43 Million
-49,715 Reduced 2.65%
1,824,290 $116 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $29.6 Million - $33.2 Million
479,034 Added 34.34%
1,874,005 $0
Q1 2019

May 02, 2019

SELL
$62.53 - $70.05 $19.1 Million - $21.4 Million
-304,953 Reduced 17.94%
1,394,971 $90.7 Million
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $13.2 Million - $17.3 Million
-218,787 Reduced 11.4%
1,699,924 $106 Million
Q3 2018

Nov 21, 2018

SELL
$71.28 - $78.92 $11.4 Million - $12.6 Million
-159,846 Reduced 7.69%
1,918,711 $148 Million
Q2 2018

Jul 31, 2018

SELL
$64.88 - $75.68 $40.7 Million - $47.5 Million
-627,295 Reduced 23.18%
2,078,557 $147 Million
Q1 2018

Apr 13, 2018

BUY
$72.84 - $88.8 $66.2 Million - $80.8 Million
909,370 Added 50.62%
2,705,852 $204 Million
Q4 2017

Jan 18, 2018

BUY
$71.15 - $83.52 $36.9 Million - $43.3 Million
518,890 Added 40.61%
1,796,482 $129 Million
Q3 2017

Oct 12, 2017

BUY
$72.11 - $85.47 $92.1 Million - $109 Million
1,277,592
1,277,592 $103 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.